Swell in Off-Label Antipsychotic Prescribing 'Not Harmless'

A growing trend of off-label, low-dose antipsychotic prescribing to treat disorders such as anxiety and insomnia has been tied to an increased risk of cardiometabolic death.

Related Keywords

Sweden ,United States ,Canada ,Toronto ,Ontario ,America ,Swedish ,Roger Mcintyre ,Jonas Berge ,University Of Toronto ,Journal Of Psychiatric Research ,Lund University ,Weak Association ,National Patient Register ,Cognitive Discover Foundation ,Medscape Medical ,Growing Trend ,Prescribed Drug Register ,Medscape Medical News ,Mood Disorders Psychopharmacology Unit ,Antipsychotics ,Neuroleptics ,Neuroleptic Drugs ,Bipolar Disorder ,Bipolar Mania ,Manic Depression ,Ipolar Affective Disorder ,Epression Manic ,Anxiety ,Anxiety Disorder ,Affective Disorders ,Atypical Antipsychotics ,Mood Disorder ,Psychopharmacology ,Select Sleep Disorders ,Narcolepsy ,Cataplexy ,Insomnia ,Idiopathic Hypersomnia ,Excessive Daytime Sleepiness ,Obstructive Sleep Apnea ,Sleep Disorder ,Ca ,